GSE130715 budesonide muscle organ 2 v 3 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE130715_budesonide_muscle organ_2_v_3_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE130715_budesonide_muscle organ_2_v_3_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE130715_budesonide_muscle organ_2_v_3_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE130715_budesonide_muscle organ_2_v_3_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

maternally expressed 3

Gene

CASTOR family member 3, pseudogene

Gene

MAGI2 antisense RNA 3

Gene

PSMG3 antisense RNA 1

Gene

zinc finger protein 542, pseudogene

Gene

myocardial infarction associated transcript

Gene

MSC antisense RNA 1

Gene

small integral membrane protein 48

Gene

TOX divergent transcript

Gene

HK2 divergent transcript

  • Gene

    maternally expressed 3


  • Gene

    CASTOR family member 3, pseudogene


  • Gene

    MAGI2 antisense RNA 3


  • Gene

    PSMG3 antisense RNA 1


  • Gene

    zinc finger protein 542, pseudogene


  • Gene

    myocardial infarction associated transcript


  • Gene

    MSC antisense RNA 1


  • Gene

    small integral membrane protein 48


  • Gene

    TOX divergent transcript


  • Gene

    HK2 divergent transcript

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.